Page last updated: 2024-10-16

carbon monoxide and Cardiomyopathy, Hypertrophic

carbon monoxide has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knaapen, P1
van Dockum, WG1
Bondarenko, O1
Kok, WE1
Götte, MJ1
Boellaard, R1
Beek, AM1
Visser, CA1
van Rossum, AC1
Lammertsma, AA1
Visser, FC1

Other Studies

1 other study available for carbon monoxide and Cardiomyopathy, Hypertrophic

ArticleYear
Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:6

    Topics: Adult; Aged; Carbon Monoxide; Cardiomyopathy, Hypertrophic; Case-Control Studies; Chronic Disease; F

2005